Pill Identifier App
Print Save or Share

Whitening Glycobest

Dosage form: cream
Ingredients: OCTINOXATE 3.5mL in 50mL, AVOBENZONE 1.5mL in 50mL, TITANIUM DIOXIDE 12.5mL in 50mL
Labeler: Zenith Medicosm SL
NDC Code: 42248-129

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts

Active Ingredient

Octinoxate 7.5%

Titanium Oxide 25%

Avobenzone 3%

Description

A cream with high concentrations of Vitamin A, Vitamin C and marine collagen, which are particularly indicated for oily and aging skin.  It combines the regenerating action of Retinol and the bateriostatic action of Vitamin C to fight premature skin aging. Softens and smoothes the skin, reduces wrinkles and gives the skin an even, radiant glow.

200ml. 6.8Fl.Oz.


Warning

TOPICAL USE

WHITENING  GLYCOBEST
octinoxate avobenzone titanium oxide cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42248-129
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (OCTINOXATE) OCTINOXATE3.5 mL  in 50 mL
AVOBENZONE (AVOBENZONE) AVOBENZONE1.5 mL  in 50 mL
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE12.5 mL  in 50 mL
Inactive Ingredients
Ingredient NameStrength
LACTIC ACID 
PROPYLPARABEN 
POLYACRYLAMIDE (1500 MW) 
CYCLOMETHICONE 
ARCTOSTAPHYLOS UVA-URSI LEAF 
LICORICE 
WATER 
EPILOBIUM ANGUSTIFOLIUM LEAF 
LEMON JUICE 
CYCLOMETHICONE 5 
LAURETH-7 
CITRIC ACID MONOHYDRATE 
fytic acid 
BUTYLENE GLYCOL 
VITAMIN A PALMITATE 
SCUTELLARIA BAICALENSIS ROOT 
METHYLPARABEN 
ENZACAMENE 
BETULA PUBESCENS BARK 
TRICLOSAN 
EDETATE DISODIUM 
DIMETHICONOL (41 MPA.S) 
POLYHYDROXYSTEARIC ACID (2300 MW) 
ETHYLPARABEN 
BUTYLPARABEN 
iSOBUTYLPARABEN 
PANTHENOL 
WHITE MULBERRY 
SODIUM METABISULFITE 
IDEBENONE 
TRICAPRYLIN 
KOJIC ACID 
METHYLISOTHIAZOLINONE 
METHYLCHLOROISOTHIAZOLINONE 
Packaging
#Item CodePackage Description
1NDC:42248-129-021 JAR (JAR) in 1 BOX
150 mL in 1 JAR
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35208/15/2011
Labeler - Zenith Medicosm SL (464239694)
Registrant - Zenith Medicosm SL (464239694)
Establishment
NameAddressID/FEIOperations
Zenith Medicosm SL464239694manufacture

Revised: 05/2012
Document Id: 0ef55387-f92b-4e32-9f13-faab49ddcb2c
Set id: 22729742-a481-40a3-9cba-7bedf054faca
Version: 1
Effective Time: 20120523
 
Zenith Medicosm SL

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Advertisement
Close

Recommended

(web2)